Vertex Pharmaceuticals (VRTX) Acquisitions (2009 - 2019)
Vertex Pharmaceuticals' quarterly Acquisitions came in at $908.4 million in Q4 2019, up 939.07% quarter-over-quarter from $87.4 million in Q1 2009.
Vertex Pharmaceuticals has reported Acquisitions for 2 years, with the latest figure at $908.4 million in Q4 2019.
- For the quarter ending Q4 2019, Acquisitions changed N/A year-over-year to $908.4 million; the trailing twelve-month figure through Dec 2022 stood at $908.4 million (changed 0.0% YoY), and the FY2022 full-year result was $295.9 million, changed N/A from the prior year.
- Acquisitions for Q4 2019 stood at $908.4 million, up from $87.4 million in the prior quarter.
- The five-year high for Acquisitions was $908.4 million in Q4 2019, with the low at $908.4 million in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 908.38 Mn |
| Mar 31, 2009 | 87.42 Mn |